Therefore, we can formulate an appropriate treatment plan based on its double-sided properties to eliminate harmful immunosuppressive cells, especially TNFR2+ Treg cells, and increase the number of immune-stimulatory cells, such as TNFR2+ CD8+ T cells, thereby activating anti-tumor reactions. Here, CD8A is linked to neoplasm.